Complex Challenges in ANCA-Associated Vasculitis: A Case of COVID-19, Cytomegalovirus Pneumonitis, and Hemorrhagic Cholecystitis Following Rituximab Therapy. [PDF]
Ezzy F +4 more
europepmc +1 more source
Resolution of PR3-ANCA-associated vasculitis after antibiotic treatment of subacute bacterial endocarditis: a case report. [PDF]
Carter KS +4 more
europepmc +1 more source
Rituximab vs. Cyclophosphamide induction therapy for patients with ANCA-associated vasculitis. [PDF]
Wu W, Wang J, Chen S.
europepmc +1 more source
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort study. [PDF]
Chavatza K +16 more
europepmc +1 more source
Urinary complement C3 fragment levels and their clinical relevance in MPO-ANCA-associated vasculitis. [PDF]
Hu Y +8 more
europepmc +1 more source
Effective Management of a Rare Case of Pediatric ANCA-Associated Vasculitis With Rituximab and Mycophenolate Mofetil. [PDF]
Fang Y +4 more
europepmc +1 more source
Challenging manifestations of ANCA-associated vasculitis treated with avacopan: two case reports. [PDF]
Chalkia A +6 more
europepmc +1 more source
Paraneoplastic Myeloperoxidase (MPO)-Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Revealing Colon Adenocarcinoma in a Patient With Controlled HIV Infection: A Case Report. [PDF]
Cespedes Useche LP +4 more
europepmc +1 more source
Clinical characteristics and predictors of in-hospital mortality in patients with ANCA-associated vasculitis complicated by diffuse alveolar hemorrhage: a retrospective cohort study. [PDF]
Gao X +6 more
europepmc +1 more source
Mapping a path forward: addressing disease burden, pathways and solutions in ANCA-associated vasculitis. [PDF]
Hellmich B.
europepmc +1 more source

